期刊
REGENERATIVE MEDICINE
卷 6, 期 3, 页码 367-406出版社
FUTURE MEDICINE LTD
DOI: 10.2217/RME.11.22
关键词
clinical translation; engraftment; human stem cells; immunodeficient; immunosuppression; neurological disease; neurotrauma; regenerative medicine; stereology; transplantation; xenograft
资金
- NINDS NIH HHS [R01 NS049885] Funding Source: Medline
There is potential for a variety of stem cell populations to mediate repair in the diseased or injured CNS; in some cases, this theoretical possibility has already transitioned to clinical safety testing. However, careful consideration of preclinical animal models is essential to provide an appropriate assessment of stem cell safety and efficacy, as well as the basic biological mechanisms of stem cell action. This article examines the lessons learned from early tissue, organ and hematopoietic grafting, the early assumptions of the stern cell and CNS fields with regard to immunoprivilege, and the history of success in stem cell transplantation into the CNS. Finally, we discuss strategies in the selection of animal models to maximize the predictive validity of preclinical safety and efficacy studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据